Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials

By sjmartinez • September 7, 2023

André F, Su F, Solovieff N, Hortobagyi G, Chia S, Neven P, Bardia A, D Tripathy, Lu YS, Lteif A, Taran T, Babbar N, Slamon D, Arteaga CL. Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials. Ann Oncol. 2023 Sep 4:S0923-7534(23)00826-8. doi: 10.1016/j.annonc.2023.08.011. Epub ahead of print. PMID: 37673211.

Tags: Advanced breast cancer, biomarkers, CDK4/6 inhibitor, Hematology/Oncology, overall survival, Publications, ribociclib

Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists

Rugo HS, Bardia A, Gradishar WJ, Hamilton EP, Hurvitz SA, Jhaveri K, Mahtani R, Tolaney SM. Expert consensus on treating HR+/HER2- metastatic breast cancer based[...]

Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking Patients

Oh MS, Garon EB, Lisberg AE, Cummings AL, Barrett A, Ashok A, Mauer E, Yilma B, Goldman JW. Brief Report: The Genomic Landscape of Small[...]

Safe Use of Immune Checkpoint Inhibitors in Patients With Autoimmune Disease in a Community Hospital Setting: A Report of Two Cases

Shah VD, Bansil S, Reed JP. Safe Use of Immune Checkpoint Inhibitors in Patients With Autoimmune Disease in a Community Hospital Setting: A Report of[...]